Gemina Laboratories Ltd. has appointed the global investment bank Stifel as its sole and exclusive financial advisor to the Company, as it considers strategic licensing and partnership opportunities for its breakthrough diagnostics technology.

Gemina Laboratories Ltd., a client of our Bristol Investor Relations company in Canada, is a biosensor and diagnostic company with a transformative, patented, proprietary chemistry that powers next-generation testing platforms for a wide range of pathogens that affect human health and wellness. 

Read the full press release here: Gemina Labs Ltd Appoints Stifel as Financial Advisor